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Abstract Vascular remodeling under conditions of growth or exercise, or during recovery from
arterial restriction or blockage is essential for health, but mechanisms are poorly understood. It has
been proposed that endothelial cells have a preferred level of fluid shear stress, or ‘set point’, that
determines remodeling. We show that human umbilical vein endothelial cells respond optimally
within a range of fluid shear stress that approximate physiological shear. Lymphatic endothelial cells,
which experience much lower flow in vivo, show similar effects but at lower value of shear stress.
VEGFR3 levels, a component of a junctional mechanosensory complex, mediate these differences.
Experiments in mice and zebrafish demonstrate that changing levels of VEGFR3/Flt4 modulates
aortic lumen diameter consistent with flow-dependent remodeling. These data provide direct
evidence for a fluid shear stress set point, identify a mechanism for varying the set point, and
demonstrate its relevance to vessel remodeling in vivo.
DOI: 10.7554/eLife.04645.001
Introduction
Homeostasis, one of the central concepts in physiology (Cannon, 1929), posits that physiological
variables have an optimum value or set point such that deviations from that set point activate
responses that return those variables toward their original value. For example, changes in central
body temperature trigger sweating, altered blood flow to the skin or shivering to restore normal
temperature. In the vasculature, arteries remodel under sustained changes in blood flow, with
increased or decreased flow triggering outward or inward remodeling, respectively, to adjust lumen
diameters accordingly (Thoma, 1893; Kamiya and Togawa, 1980; Kamiya et al., 1984; Langille and
O’Donnell, 1986; Langille et al., 1989; Langille, 1996; Tronc et al., 1996; Tuttle et al., 2001). These
studies have given rise to the concept that the endothelium encodes a fluid shear stress set point that
governs remodeling responses (Rodbard, 1975; Cardamone and Humphrey, 2012) (Figure 1A).
While appealing, there is no direct evidence for such a mechanism. Moreover, if it exists, the set point
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generally have very different magnitudes of fluid shear stress (Lipowsky et al., 1980; Dixon et al.,
2006; Suo et al., 2007).
Arterial remodeling is crucial in normal physiological adaptation to growth and exercise, and is
a major determinant of outcomes in cardiovascular disease (Kohler et al., 1991; Corti et al., 2011;
Padilla et al., 2011). Outward remodeling of atherosclerotic vessels helps to maintain lumen diameter
and blood flow, whereas inward remodeling leads to ischemia associated with angina and peripheral
vascular disease (Ward et al., 2000). Additionally, flow-dependent remodeling of small blood vessels
near sites of myocardial infarction provides collateral circulation that plays a major role in restoring
cardiac function (Heil and Schaper, 2004), whereas failure to remodel is a major factor in progression
to heart failure.
Flow-dependent remodeling is initiated by inflammatory activation of the endothelium, leading to
recruitment of leukocytes that assist with remodeling in several ways including secretion of matrix
metalloproteinases, cytokines and extracellular matrix proteins (Silvestre et al., 2008; Schaper, 2009;
Silvestre et al., 2013). Once the remodeling phase is completed, inflammation is resolved and the
vascular wall stabilized. NF-κB plays a major role in the initial inflammatory activation (Castier et al.,
2009; Sweet et al., 2013), whereas signaling through TGF-β is critical in the anti-inflammatory,
stabilization phase (Walshe et al., 2009) .
These considerations led us to investigate the existence of a fluid shear stress set point and its
relevance to vascular remodeling. Our results provide strong evidence for a fluid shear stress set point
eLife digest Blood and lymphatic vessels remodel their shape, diameter and connections during
development, and throughout life in response to growth, exercise and disease. This process is called
vascular remodeling.
The endothelial cells that line the inside of blood and lymphatic vessels are constantly exposed to
the frictional force from flowing blood, termed fluid shear stress. Changes in shear stress are sensed
by the endothelial cells, which trigger vascular remodeling to return the stress to the original level. It
has been proposed that remodeling is governed by a preferred level of fluid shear stress, or set
point, against which deviations in the shear stress are compared. Thus, changing the fluid flow
through a blood vessel increases or decreases shear stress, which results in the vessel remodeling to
restore the original level of shear stress. Like all remodeling, this process involves inflammation to
recruit white blood cells, which assist with the process.
Baeyens et al. investigated whether such a shear stress set point exists and what its biological
basis might be using cultured endothelial cells from human umbilical veins. These cells remained
stable and in a resting state when a particular level of shear stress was applied to them; above or
below this shear stress level, the cells produced an inflammatory response like that seen during
vascular remodeling. This suggests that these cells do indeed have a set point for shear stress. The
same response occurred in human lymphatic endothelial cells, although in these cells the shear stress
set point was much lower, correlating with the low flow in lymphatic vessels.
Baeyens et al. then discovered that the shear stress set point is related to the level of a protein
called VEGFR3 in the cells, which was recently found to participate in shear stress sensing.
Endothelial cells from lymphatic vessels normally produce much greater quantities of VEGFR3 than
those from blood vessels. Reducing the amount of VEGFR3 in lymphatic endothelial cells increased
the set point shear stress, while increasing the levels in blood vessel cells decreased the set point.
This suggests that the levels of this protein account for the difference in the response of these two
cell types. Baeyens et al. then tested this pathway by reducing the levels of VEGFR3 in zebrafish
embryos and in adult mice. In both animals, this caused arteries to narrow, showing that VEGFR3
levels also control sensitivity to shear stress—and hence vascular remodeling—inside living
creatures.
Understanding in detail how vascular remodeling is regulated could help improve treatments for
a wide range of cardiovascular conditions. To do so, further work will be needed to develop methods
to control the sensitivity of endothelial cells to shear stress and to identify other proteins that might
specifically control the narrowing or the expansion of vessels in human patients.
DOI: 10.7554/eLife.04645.002
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in vascular endothelium. They also show that vascular
and lymphatic endothelium have different set points,
that this difference is mediated by differences in
expression of VEGFR3, and provide evidence that
this pathway controls artery remodeling in vivo.
Results
Is there a set point for fluid shear
stress?
To test the existence of a shear stress set point,
we built a flow chamber that creates a gradient of
shear stress along a single culture slide. Following
a previous design (Usami et al., 1993), the width
of the chamber progressively decreases to yield
a linear gradient (Figure 1B). We then measured
several biological responses associated with fluid
shear stress and vascular remodeling. To assay
responses as a function of shear stress, we took
successive microscopic images along the cham-
ber. Depending on localization, these responses
correlated with calculated values of shear stress.
Changing the gasket thickness and flow rate
allowed us to control the range of shear stress
for each experiment (Figure 1B).
We first measured endothelial cell alignment in
flow, which is a well-studied response associated
with vessel stabilization and suppression of in-
flammatory pathways (Levesque and Nerem,
1985; Wang et al., 2012; Baeyens et al., 2014).
Alignment was quantified by measuring the angle
between the major axis of the nucleus and the
flow direction (Baeyens et al., 2014). Human
umbilical vein endothelial cells (HUVECs) were
subjected to 16 hr of laminar shear stress
ranging from 2 to 60 dynes.cm−2. HUVECs
aligned in the direction of the flow, between
approximately 10 and 20 dynes.cm−2, but were misaligned or oriented perpendicularly, against
the flow direction, outside this range (Figure 2A, Figure 2—figure supplement 1). This result
agrees with previous studies showing perpendicular alignment of endothelial cells under very
high shear stress (Viggers et al., 1986; Dolan et al., 2011; Dolan et al., 2012).
Next, to assess NF-κB activation, we measured the nuclear translocation of the p65 subunit of
NF-κB. NF-κB showed baseline activation in cells without flow, which decreased between
approximately 10 and 25 dynes.cm−2, and dramatically increased at very high shear (Figure 2B,
Figure 2—figure supplement 1). The suppression of NF-κB translocation in this range is
consistent with previous observations that sustained laminar flow is anti-inflammatory (Mohan
et al., 1997; Berk, 2008). Lastly, we measured the activation of TGFβ/SMAD signaling by assaying
nuclear translocation of Smad1. Strikingly, flow induced Smad translocation with a sharp
maximum between 10 and 20 dynes.cm−2 and repressed translocation at higher values
(Figure 2C, Figure 2—figure supplement 1). The results obtained with the gradient chamber
were validated by examining 2, 12 and 50 dynes.cm−2 using normal parallel flow chambers
(Figure 2—figure supplement 1).
Taken together, these results show that HUVECs have a biphasic response to shear stress such that
anti-inflammatory, stabilization pathways are activated between approximately 10 and 20 dynes.cm−2,
while lower or higher shear stress is pro-inflammatory. This behavior is consistent with a shear stress
set point within the range of 10 and 20 dynes.cm−2 for these cells.
Figure 1. Testing the set point hypothesis.
(A) Definition of the ‘shear stress set point’. (B) Picture
of a silicone gasket used in the gradient flow chamber
with the corresponding calculation of the theoretical
shear stress level across the channel with two different
conditions of gasket thickness and flow rate.
DOI: 10.7554/eLife.04645.003
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Analysis of lymphatic endothelial cells
An essential aspect of the set point hypothesis is that it must differ between different types of vessels.
In vivo, average shear stress in lymphatic vessels is much lower than in arteries or veins (Lipowsky
et al., 1980; Dixon et al., 2006; Suo et al., 2007). We therefore examined the behavior of human
dermal lymphatic endothelial cells (HDLEC), using modified chamber parameters to obtain values of
shear stress from 0.5 to 20 dynes.cm−2 (Figure 1). In these experiments, HUVECs aligned between
8 and 20 dynes.cm−2, (Figure 2A and Figure 3A) whereas HDLEC aligned maximally between 4 and
6 dynes.cm−2 (Figure 3A, Figure 3—figure supplement 1). The minimum for NF-κB translocation also
shifted to between 4 and 10 dynes.cm−2 (Figure 3B, Figure 3—figure supplement 1), which
corresponds well to in vivo measurements (Dixon et al., 2006). These results indicate that lymphatics
have a higher sensitivity to shear stress compared to HUVECs, consistent with the set point concept.
VEGFR3 expression regulates the set point for shear stress in vitro
A number of shear stress responses, including cell alignment and NF-κB activation, require
mechanotransduction via VEGFR2, whose ligand-independent transactivation by flow requires
PECAM-1 and VE-cadherin (Tzima et al., 2005). We therefore considered whether differences in
expression of these proteins might account for the difference in flow sensitivity between HUVECs and
HDLECs. However, no major differences in levels of these proteins were observed (Figure 3C).
VEGFR3, a close homolog of VEGFR2, is highly expressed in lymphatic cells (Kaipainen et al. 1995)
and recent work in our lab showed that it is activated by flow in vascular endothelial cells similarly to
VEGFR2 (Coon et al., 2015). These considerations prompted us to examine levels of this receptor as
well, which showed approximately 10-fold higher expression in lymphatic ECs compared to
HUVECs (Figure 3C). We therefore considered whether VEGFR3 levels might be responsible for
the higher flow sensitivity of lymphatic ECs.
HDLECs were therefore transfected with VEGFR3 siRNA, which reduced its expression to
approximate the level in HUVECs (Figure 4A). We also transduced HUVECs with adenovirus coding
for hVEGFR3-GFP (Figure 4A), which increased levels by ∼10-fold and infected >90% of the cells
(Figure 4—figure supplement 1). Cell alignment in flow was then analyzed. Depletion of VEGFR3 in
HDLECs shifted the optimal alignment to between 10 to 20 dynes.cm−2 (Figure 4B, Figure 4—figure
supplement 2), similar to HUVECs. Conversely, over-expression of VEGFR3 in HUVECs decreased the
optimal response toward the lower shear stress levels seen with lymphatic ECs (Figure 4C, Figure
4—figure supplement 2). Taken together, these results show that VEGFR3 levels are a major
determinant of the difference in shear stress sensitivity between HUVECs and HDLECs.
We also confirmed VEGFR3 activation by flow in lymphatic endothelial cells. Onset of flow
stimulated VEGFR3 phosphorylation maximally at 6 dynes.cm−2 in HDLEC (Figure 5), which
corresponds well to the set point of around 5 dynes.cm−2 in these cells. HUVECs, by contrast,
exhibited a weaker response that was shifted to higher shear, consistent with their higher set.
VEGFR3 controls blood vessels diameter in zebrafish, in a VEGF-C-
independent manner
To test whether VEGFR3 levels control sensitivity to shear stress and vascular remodeling in vivo, we
examined Danio rerio (zebrafish). This system has the advantage that development proceeds normally
without blood flow, thus, fluid shear stress can be altered or even stopped without affecting viability
(Langheinrich et al., 2003). The notion that levels of VEGFR3 (Flt4 in zebrafish) determine the shear
stress set point predicts that reducing VEGFR3 expression will induce inward remodeling of the
vessels in order to increase shear stress and restore normal signaling. We used a strain in which blood
vessels are labeled by expression of kdrl:mCherry (VEGFR2) and flt4:Citrine (VEGFR3) reporters. kdrl:
mCherry was highly visible in the dorsal aorta and the posterior cardinal vein, whereas flt4:Citrine was
low (though detectable) in the dorsal aorta and higher in the cardinal posterior vein and the
developing thoracic duct (Figure 6, Figure 6—figure supplement 1). Flt4/VEGFR3 and its ligand,
VEGF-C, are associated with development of lymphatic vasculature and segmental arteries in
zebrafish (Covassin et al., 2006; Kuchler et al., 2006). To assay the effect of FLT4 and VEGFC
dosage on vessels diameter, we injected zebrafish embryos at the one cell stage with previously
validated VEGFC and FLT4 morpholinos at two different concentrations. These antisense oligos
target the respective mRNAs and induce a dose dependent loss of function (Nicoli et al., 2012;
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Villefranc et al., 2013). At 72 hr post fertiliza-
tion (hpf), the progressive inhibition of VEGFC
did not perturb the remodeling of blood vessel
or vessel diameter but as expected inhibited
the development of the thoracic duct, the first
zebrafish lymphatic vessel (Yaniv et al., 2006)
(Figure 6, white stars). By contrast, progressive
inhibition of FLT4 reduced the diameter of the
dorsal aorta with loss of thoracic duct evident
at a higher dose of FLT4 morpholino (Figure 6).
These results suggested that VEGF-C-
independent Flt4 activation is required for
artery diameter and exclude an indirect effect
of lymphatic development on the artery
development. Interestingly, a similar decrease
of the dorsal aorta diameter can be observed in
a recent paper (Kwon et al., 2013). Although
these authors focused on the growth of
motoneurons, the dorsal aorta is readily visible
in images of Flt1 mCherry reporter embryos; its
diameter is obviously smaller in expando
embryos expressing a kinase dead Flt4, as well
as in wildtype embryos treated with Flt4
morpholino or VEGFR3 inhibitors but not
after injection with VEGFC morpholino, in
accordance with our own observations.
To test the role of flow in this process, embryos
were treated with 40 μM nifedipine, a voltage-
dependent calcium channel blocker that stops the
heart and thus blood flow (Langheinrich et al.,
2003). Blocking flow led to a decreased vessel
diameter (Figure 6, Figure 6—figure
supplement 1), supporting the role of shear
stress in determining lumen size. Interestingly,
lumen diameter was similar in embryos treated
with high dose Flt4 morpholino and with
nifedipine. To test whether Flt4 acts on a flow
pathway, we then combined these treatments.
Strikingly, in the absence of flow, neither Flt4
nor VEGF-C morpholinos caused further
changes in vessel size. Taken together, these
results support the conclusion that VEGF-C-
independent activation of VEGFR3 by flow
may determine the endothelial cell sensitivity
to flow and vessel remodeling, consistent
with the existence of a fluid shear stress set
point.
Interestingly, ligand-independent responses
for VEGFR3 are consistent with developmental
mouse phenotypes: deletion of VEGF-C and
VEGF-D does not affect the development and
maturation of blood vessels during mice
development, while deletion of VEGFR3 does
(Haiko et al., 2008). Ligand-dependent
responses are thus required for lymphangio-
genesis but probably not for flow responses.
Figure 2. Set point for shear stress. (A) Cell orientation:
the average orientation of HUVEC nuclei was measured
in each picture, to obtain average orientation at a given
shear stress. (n = 16, Mean ± SEM, ANOVA: F = 15.02,
p < 0.0001). With no flow, cell orientation was random
(average = 45˚). (B) NF-κB activation: p65 nuclear
Figure 2. continued on next page
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VEGFR3 and artery remodeling in
mice
Lastly, we investigated whether VEGFR3 controls
artery remodeling in mice in a similar manner.
Expression of VEGFR3 in adult arteries has been
reported to be low (Gu et al., 2001; Witmer
et al., 2002; Tammela et al., 2008), thus, we first
verified its transcription in the thoracic aorta.
Using a transgenic Vegfr3::YFP reporter mouse
(Calvo et al., 2011), expression of YFP was
readily detected, confirming Vegfr3 expression in
adult arteries (Figure 7A). We confirmed this
observation by staining a longitudinal section of
the thoracic aorta with an anti-VEGFR-3 antibody
(Figure 7B). Interestingly, VEGFR3 expression
was not uniform: weaker expression was
detected in the outer curvature or some portions
of the carotid artery, associated with higher shear stress, while stronger expression was observed in
the inner curvature, associated with low shear stress (Figure 7—figure supplement 1).
Because deletion of Vegfr3 in mice leads to major cardiovascular defects and embryonic lethality
(Dumont et al., 1998), we used an inducible knock out strategy in adult Vegfr3fl/fl mice (Haiko et al.,
2008) that also contain an endothelium-specific, tamoxifen-inducible Cre (Cdh5-CreERT2) allele (Wang
et al., 2010). Cdh5 CreERT2, Vegfr3fl/fl mice, referred as EC iΔR3, grow normally without any defect prior
to tamoxifen injection. Two month old Vegfr3fl/fl (wild-type, WT) and EC iΔR3 mice were injected with
tamoxifen and examined at 1, 2, 3 or 7 weeks. 1 week after tamoxifen injection, no VEGFR3 expression
was visible in the thoracic aorta (Figure 7B) and in the ear skin lymphatics of EC iΔR3 mice (Figure 7C).
3 weeks after deletion of Vegfr3, the dermal lymphatic network in the skin was completely intact but
vessel diameter was dramatically decreased (WT: 38 ± 5 μm and EC iΔR3: 22 ± 2 μm, n = 4, p < 0.001).
We also observed a ∼15% reduction of the diameter of the descending aorta (Figure 7D,E). No further
change was observed when mice were examined at 7 weeks (Figure 7E), indicating that vessels
remodeled and then stabilized. No change in body weight was observed 3 weeks after injection (28.4 g
± 2 for WT and 28.3 g ± 2.7 for EC iΔR3 mice). The curvature of the aortic arch was also reproducibly
decreased after excision, an unexpected result that we have not further investigated.
To investigate the role of remodeling pathways, we stained longitudinal sections of the thoracic
aorta for MMP9, a matrix metalloprotease involved in flow-dependent vascular remodeling (Bond
et al., 1998; Godin et al., 2000;Magid et al., 2003). Following Vegfr3 deletion, MMP9 in the thoracic
aorta was highly elevated at 1 week but decreased to baseline at later times (Figure 7F). This
observation strongly supports the notion that Vegfr3 deletion induces inward remodeling of the
thoracic aorta which is followed by stabilization. Increased MMP9 expression may be induced through
NF-κB (Sun et al., 2007). We hypothesize that elevating the set point causes the endothelium to
signal low shear, which induces inward remodeling. Together, these data support the concept that
vessel lumen diameter is controlled by a VEGFR3-dependent shear stress set point.
Discussion
Living organisms have developed an extensive repertoire of mechanisms to adapt to stresses and
maintain homeostasis. For more than a century, investigators have observed effects suggesting that
the blood flow controls vascular diameter (Thoma, 1893; Langille and O’Donnell, 1986; Langille
et al., 1989; Langille, 1996), a mechanism that would optimize perfusion by adjusting vascular
morphology in response to tissue demand. It has been hypothesized that, as for thermoregulation,
there is an optimal value of flow which is maintained through feedback mechanisms to prevent
deviation from this value. This is what we term the ‘shear stress set point’ theory (Rodbard, 1975).
The current data show that HUVECs align in the direction of flow, inhibit NF-κB and activate Smads
within a narrow range of fluid shear stress magnitudes. This range corresponds to the physiological
flow within the umbilical vein estimated at around 8.4 to 12.5 dynes.cm−2 ((Kiserud and Rasmussen,
1998; Boito et al., 2002; Christensen et al., 2014); shear stress = 8 × viscosity (velocity/diameter),
Figure 2. Continued
translocation in HUVEC was measured either in no
flow (dotted line: average) or after 16 hr of flow in
the gradient chamber (n = 6, Mean ± SEM, ANOVA:
F = 10.97, p < 0.0001). (C) Smad1 activation: Smad1
nuclear translocation in HUVECs was measured without
flow (dotted line: average) or after 16 hr of flow in
the gradient chamber (n = 6, Mean ± SEM, ANOVA:
F = 13.47, p < 0.0001).
DOI: 10.7554/eLife.04645.004
The following figure supplement is available for figure 2:
Figure supplement 1. (A) Quantification of cell
orientation, p65 nuclear translocation or smad1 nuclear
translocation without flow or after 16 hr laminar flow at
the indicated values (NS: not significant, *: p < 0.05, **:
p < 0.01, ****: p < 0.0001).
DOI: 10.7554/eLife.04645.005
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with viscosity = 0.06–0.09 poisse, velocity = 7.1 cm.s−1 and diameter = 4.1 mm). These results imply
that physiological flow inhibits inflammatory pathways and activates anti-inflammatory/stabilization
pathways. By contrast, cells in low or high flow fail to align, activate NF-κB and suppress Smads.
We propose that these responses are involved in the vessel remodeling that reestablishes optimal
blood flow.
It is known that inflammation is a critical component of flow-dependent as well as other forms of
vessel remodeling (Silvestre et al., 2008; Schaper, 2009; Silvestre et al., 2013). It has been recently
demonstrated that inhibiting NF-κB impairs outward remodeling associated with increased shear
stress as well as aneurysm formation (Saito et al., 2013). On the other hand, defective Smad1
signaling in the endothelium is associated with hereditary haemorrhagic telengiectasia (HHT), which is
Figure 3. Set point in HUVECs vs lymphatic endothelial cells. (A) The average orientation of venous cell (HUVEC) or
lymphatic cell (HDLEC) nuclei across the slide was measured as in Figure 2A. (n = 11, Mean ± SEM). The difference
between HUVECs and HDLECs is statistically significant (ANOVA Two-way, p < 0.0001). (B) NF-κB activation: p65
nuclear translocation in HDLEC was measured either in no flow (dotted line: average) or after 16 hr of flow in the
gradient chamber (n = 4, Mean ± SEM, ANOVA: F = 34.32, p < 0.0001). (C) Expression of VE-cadherin, PECAM-1,
VEGFR2 and VEGFR3, proteins involved in the shear stress mechanotransduction through the junctional complex.
Actin was used as a loading control.
DOI: 10.7554/eLife.04645.006
The following figure supplement is available for figure 3:
Figure supplement 1. Representative pictures of HDLEC probed for DAPI and p65 at 5 and 20 dynes.cm−2.
DOI: 10.7554/eLife.04645.007
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characterized by the development of unstable,
arteriovenous malformations (Dupuis-Girod
et al., 2010). Interestingly, these malformations
are preceded by increased vascular lumen di-
ameter, which occurs in a flow dependent
manner (Corti et al., 2011). These observations,
combined with ours, suggest that these two
signaling pathways contribute to balanced con-
trol of the vessel caliber.
Fluid shear stress varies among different types
of vessels, and to some extent even within the
same vessel, suggesting that different cells must
have different set points for shear stress,
depending on their location. Relevant to our
experiments, the shear stress in the human
umbilical vein is estimated at around 8.4–12.5
dynes/cm−2 whereas lymphatic vessels have
highly pulsatile flow with peaks values at around
4–8 dynes.cm−2 and averages that are much
lower (Dixon et al., 2006). The shear stress set
point model therefore predicts that these cell
types will have different set points, which was
borne out in our studies. Furthermore, we found
that this difference can be largely accounted for
by differences in VEGFR3 expression. This re-
ceptor, a close homolog of VEGFR2, is also
activated in response to flow. Both expression
levels in vivo (Witmer et al., 2002) and our
functional experiments in vitro lead to the
conclusion that high expression of VEGFR3
increases sensitivity to shear to give a low shear
stress set point, while low expression of VEGFR3
is associated with higher set points. However, it is
highly likely that other mechanotransducers or
mediators influence set point values. While we
did not observe any major difference in PECAM-1
and VE-cadherin expression between HDLEC and
HUVEC, these two proteins can vary between
different vascular beds (Pusztaszeri et al., 2006;
Herwig et al., 2008), which might also affect the
set point. We used HUVECs as a model for blood
endothelial cells because they are readily avail-
able and their response to shear stress is well
characterized. However, it has been recently
showed that arterial and venous markers greatly
diminish in culture (Aranguren et al., 2013), thus,
whether they fully represent typical venous cells
in vivo should be treated with caution. Compar-
ing fresh primary cells from veins and arteries will
be an interesting direction for future work.
Mechanotransducers apart from the junctional
complex are also likely to be important. There
must also be pathways that distinguish high and
low shear to initiate outward vs inward remodel-
ing. Future work will be required to explore these
Figure 4. VEGFR3 expression controls the shear stress
set point. (A) Western Blot of VEGFR3 and GFP in
HDLECs with and without VEGFR3 siRNA (10 nM), and in
HUVECs with and without adenoviral expression of
hVEGFR3-GFP. Actin serves as a loading control. (B)
Effect of VEGFR3 siRNA in HDLECs on set point. Cell
alignment was assayed after shear stress for 16 hr (n = 6).
Data were smoothed with a LOWESS fit to improve
visualization (mean ± SEM; HDLEC vs HDLC + VEGFR3
siRNA: p = 0.004; HDLEC + VEGFR3 siRNA vs HUVEC:
p = 0.45). (C) Effect of VEGFR3 over-expression on set
Figure 4. continued on next page
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pathways in more detail and their relevance to
vascular remodeling.
The notion that vascular remodeling is gov-
erned by a shear stress set point, which is itself
set by activation of various receptors and
signaling pathways, may be relevant to a number
of applications. Recovery from atherosclerotic
luminal narrowing or myocardial infarction is
thought to proceed in part via flow-dependent
vessel remodeling (Heil and Schaper, 2004).
Vascular graft adaptation also requires activation
of signaling pathways activated by high shear
stress to promote healing of the graft by
preventing intimal proliferation (Kohler et al.,
1991). Arteriovenous malformations are also
thought to have a flow-dependent component
(Corti et al., 2011). Thus, further understanding
of the molecular sensors and downstream signal-
ing pathways that control flow-dependent
remodeling is relevant to a broad range of vascular dysfunction.
Materials and methods
Cell culture
Human Umbilical Vein Endothelial Cells (HUVECs) pooled from three different donors were obtained
from the Yale Vascular Biology and Therapeutics program and cultured in M199 medium
supplemented with 20% Fetal Bovine Serum, 50 μg.ml−1 of Endothelial Cell growth Supplement
(ECGS) prepared from bovine hypothalamus, 100 μg.ml−1 heparin, 100 U.ml−1 penicillin and 100 μg.ml−1
streptomycin. They were used between passage 3 and 7. Human Dermal Lymphatic Endothelial Cells
(HDLECs) were obtained from Lonza (Basel, Switzerland) and cultured in EGM-2 MV medium and used
from passage 5 to 7. Cells were starved in M199 medium supplemented with 5% FBS and 100 U.ml−1
penicillin and 100 μg.ml−1 streptomycin for a minimum of 4 hr before further treatments.
Shear stress
Cells were seeded on tissue culture plastic slides cut from 150 mm tissue culture dishes (Falcon),
coated with 20 μg.ml−1 fibronectin. Confluent cells were subjected to steady laminar shear stress in
a modified parallel plate flow chamber (Figure 1) in which the gasket was a silicon sheet of either 0.8
or 1.6 mm height (Grace Bio-Labs, Bend, OR, #664172 and #664283) cut to generate a linear gradient
of shear stress, calculated from (Usami et al., 1993). Flow was applied for 16 hr in starvation medium.
Cells were then fixed with 4% formaldehyde in PBS for 10 min, permeabilized with 0.5% Triton x-100
in PBS for 10 min, blocked with Startingblock buffer (ThermoScientific) for 30 min at room
temperature and probed overnight at 4˚C with a primary antibody diluted in Startingblock buffer.
Slides were stained with Hoechst 33342 to label nuclei, with rabbit anti-p65 antibody (Cell Signaling)
to label NF-κB, and with rabbit anti-Smad1 antibody (Cell Signaling).
Image analysis
Images were acquired with a Perkin Elmer spinning disk confocal microscope equipped with an
automated stage which was used to take successive pictures along the chamber channel. Masks of the
images were made using a combination of an adaptive histogram equalization algorithm with intensity
and size thresholding. Cell orientation was calculated by taking the masks of the cell nuclei, fitting to
an ellipse, and finding the angle between the flow direction and the major-axis of the ellipse. Nuclear
translocation was computed by taking the mask of the nucleus and determining the integrated
intensity of the transcription factor stain (Smad1 or p65) in the nucleus and in the whole cell. The
‘translocation factor’ (TF) was calculated by dividing the integrated intensity in the nucleus by the
value for the whole cell. If the entire signal is localized to the nucleus, TF = 1, while if the entire signal
is cytoplasmic, TF = 0.
Figure 4. Continued
point. Alignment after 16 hr flow was assayed in
HUVECs infected with adenovirus expressing mCherry
or hVEGFR3-GFP as before. Data were smoothed with
a LOWESS fit to improve visualization (n = 10, values are
means ± SEM; HUVEC +mCherry vs HUVEC + VEGFR3-
GFP: p < 0.0001).
DOI: 10.7554/eLife.04645.008
The following figure supplements are available for figure
4:
Figure supplement 1. (A) Representative pictures of
HUVEC cells expressing hVEGFR3-GFP (GFP signal
displayed) after 16 hr of stimulation at 5 and 20
dynes.cm−2.
DOI: 10.7554/eLife.04645.009
Figure supplement 2. Non-smoothened data of the
graphs displayed in Figure 4B,C.
DOI: 10.7554/eLife.04645.010
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siRNA transfection and adenoviral expression
Depletion of VEGFR3 was achieved by transfecting 10 nM siRNA (L-003138-00 OnTarget Smartpool
Human FLT4, ThermoScientific) with Lipofectamine RNAi Max (Invitrogen), following the manufac-
turer’s instructions. Transfection efficiency was assessed by Western-blot. Human VEGFR3-GFP was
cloned in adenoviral (pAd) expression vector. Cells were infected with the virus in medium with
polybrene (5 mg/ml) overnight and used 48 hr later.
FACS
GFP expression in HUVEC or HUVEC infected with VEGFR3-GFP was assayed on a Stratedigm S1000EX
(Stratedigm, San Jose, CA). Data were analyzed with the FlowJo software (TreeStar, Ashland, OR).
Western blotting
Cells were washed with cold PBS and proteins extracted with Laemmli’s buffer. Samples were run on
10 or 12% SDS-PAGE and transferred onto nitrocellulose membranes. The membranes were blocked
with StartingBlock buffer (ThermoScientific) and probed with primary antibodies overnight at 4˚C:
VEGFR3 (R&D systems), phospho-VEGFR3 (Cell Applications), VEGFR2 (Cell Signaling), PECAM-1
(Abcam), VE-cadherin (Santa Cruz), GFP (Invitrogen) and actin (Santa Cruz). DyLight conjugated
fluorescent secondary antibodies (680 nm and 800 nm, Thermoscientific) or HRP-conjugated antibodies
were used to detect primary antibodies. Bands were detected and quantified with an Odyssey infrared
imaging system for DyLight antibodies (Li-Cor) or a BioRad western blot imaging system (Bio Rad).
Zebrafish
Zebrafish were grown and maintained according to protocols approved by the Yale University
Animal Care. The Tg(kdrl:mCherry; flt4:citrine) was used (Bussmann and Schulte-Merker, 2011).
Figure 5. VEGFR3 activation by shear stress. HDLECs (left) and HUVECs (right) were stimulated for 15 min with shear
stress at the indicated levels. VEGFR3 transactivation was assayed by phosphorylation on Y1230, detected by
Western blotting with pY1230 antibody (n = 5 independent experiments; *: p < 0.05, **: p < 0.01, ****: p < 0.0001).
DOI: 10.7554/eLife.04645.011
Baeyens et al. eLife 2015;4:e04645. DOI: 10.7554/eLife.04645 10 of 16
Research article Cell biology | Human biology and medicine
Morpholinos (Nicoli et al., 2012) were injected at the indicated concentrations and morphants were
observed in a confocal microscope (SP5 Leica Microsystems). Images captured using Leica
application suite software. Chemical treatment with nifedipine 40 μM was performed as previously
described, 4 hr prior imaging (Bussmann et al., 2011).
Mice
All animal experiments were approved by the Institutional Care and Use Committee of Yale University.
The Vegfr3::YFP (Calvo et al., 2011), Cdh5CreERT2 (Pitulescu et al., 2010; Wang et al., 2010),
Vegfr3flox/flox (Haiko et al., 2008) mice were described previously. Cdh5CreERT2 mice were crossed
with Vegfr3flox/flox mice to generate endothelial-specific inducible Vegfr3 mutant mice. 6–8 weeks old
Vegfr3flox/flox mice, with or without the Cre recombinase, were injected intra-peritoneally with 2 mg
tamoxifen (TX; at 20 mg/ml in peanut oil (Sigma) with 10% Ethanol) once per day for 5 consecutive
days (induction period). Mice were euthanized then fixed by perfusion with 3.7% formaldehyde 1, 2, 3
or 7 weeks after induction. Ear tissue was fixed overnight in 3.7% formaldehyde. The ear skin was
removed, cleaned of connective tissue and cartilage, and permeabilized for 4 hr in permeabilization
buffer (1% BSA, 1% NGS, 0.5% Tween in PBS). The skin was then incubated with antibody against
LYVE-1 or VEGFR3, in 50% permeabilization buffer/50% PBS for 2 days at 4˚C. After washing, the skin
was incubated with secondary antibodies overnight 4˚C in the same buffer. The skin was then flat
mounted in Fluoromount G (Southern Biotech) and imaged with a Perkin Elmer spinning disk confocal
microscope with a 20× objective. The aorta was removed, cleaned of all connective tissue, fixed
overnight in 3.7% formaldehyde at 4˚C and embedded in paraffin. Paraffin embedding and sectioning
Figure 6. VEGFR3 (Flt4) controls blood vessel caliber in zebrafish. Representative pictures of the dorsal aorta (DA),
posterior cardinal vein (PCV) and thoracic duct (white *) at 72 hr post-fertilization (hpf) in wild type zebrafish embryos
or embryos injected with Flt4 (VEGFR3) morpholino at 0.06 or 0.1 mM, or with VEGF-C morpholino at 0.06 or 0.1 mM.
The mCherry reporter driven by the KDR (VEGFR2) promoter (kdrl:mCherry) is depicted in red and the citrine
reporter driven by the Flt4 promoter (flt4:citrine) is depicted in green. Scale = 20 μm and applies to all pictures. n =
6-15 fishes for each condition, whiskers represents the minimum and maximum data point (NS: non-significant, ***:
p < 0.001 and ****: p < 0.0001, ANOVA).
DOI: 10.7554/eLife.04645.012
The following figure supplement is available for figure 6:
Figure supplement 1. Representative pictures of the dorsal aorta (DA) and posterior cardinal vein (PCV) and
developing thoracic duct (*) in wild type zebrafish embryos with a citrine reporter associated to Flt4 promoter (flt4:
citrine) before and approximatively 2 hr after nifedipine treatment.
DOI: 10.7554/eLife.04645.013
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Figure 7. continued on next page
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were performed by the Yale Pathology department, in the Tissue Microarray facility. Aortas were cut
longitudinally, paraffin was removed in xylene baths and sections progressively rehydrated before
antigen retrieval for 30 min at 95˚C in citrate buffer (10 mM sodium citrate, 0.05% Tween, pH = 6).
Sections were blocked for 30 min in StartingBlock blocking buffer (ThermoScientific) and probed
either with anti-MMP9 antibody (Abcam, 1/400), anti-VEGFR3 antibody (R&D) or anti-GFP antibody
(Invitrogen, 1/400). Slides were then washed 3× in PBS-Tween and once in PBS, then incubated with
donkey-anti rabbit AlexaFluor 647 secondary antibody (Molecular Probes, 1 hr at RT, 1/500). Slides
were washed 3× in PBS-Tween and once in PBS, then mounted in Fluoromount G (Southern Biotech).
Slides were imaged with a Nikon Eclipse 80i epifluorescence microscope. Image analysis of MMP9
staining was performed by measuring the area under the curve of the fluorescence signal coming from
the media in 4 different 20× pictures for each individual aorta. The fluorescence profile was obtained
with MeasureEndo, an ImageJ macro.
Statistics
Values indicated in the text are mean ± SD. At least three independent experiments were performed
for each condition. Statistical tests were performed by using either analysis of variance tests (ANOVA)
or unpaired Student’s t-tests. The ANOVA test performed on Figures 2 and 3 tested the null
hypothesis that shear stress magnitude does not have an effect on either cell orientation or p65 and
Smad1 nuclear translocation.
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Figure 7. Continued
Figure 7. Transient vascular remodeling in EC iΔR3mice. (A) Longitudinal paraffin section of the thoracic aorta of a Vegfr3::YFP (VEGFR3 reporter) mouse.
YFP was detected with an anti-GFP antibody. Scale bar = 50 μm. (B) VEGFR3 and DAPI staining of a longitudinal section of the thoracic aorta of Vegfr3fl/fl
(WT) or EC iΔR3 mice, 3 weeks after Tx injection. Scale bar: 50 μm. (C) Lyve1 and VEGFR3 staining of the lymphatic network in ear skin from Vegfr3fl/fl (WT)
or EC iΔR3 mice. Pictures were taken 1 week after Tx injection. Scale bar = 50 μm. (D) Aorta from oil injected-EC iΔR3 (WT) or Tx-injected EC iΔR3 mice,
2 weeks after Tx injection. Scale bar = 1 mm. (E) Diameters (graph on right) were measured in thoracic aortas (images on left) from Vegfr3fl/fl (WT) or EC
iΔR3 mice, 3 weeks (WT: n = 8 and EC iΔR3: n = 7) and 7 weeks (WT: n = 6 and EC iΔR3: n = 5) after Tx treament (whiskers indicate the minimum and
maximum data point, ***: p < 0.001, ANOVA). The measurement was performed right after the curvature, 1 mm below the subclavian artery bifurcation.
(F) Longitudinal paraffin sections of the thoracic aorta from Vegfr3fl/fl (WT) or EC iΔR3 mice or EC iΔR3 mice, probed for MMP9 (blue) and nuclei (red) after
injection of Tx for the indicated time (WT is 1 week post-injection). Distribution of the area under the curve of MMP9 fluorescence from the media is
plotted on the left (n ≥ 3 mice for each condition, whiskers are 10–90%, cross is the arithmetic mean).
DOI: 10.7554/eLife.04645.014
The following figure supplement is available for figure 7:
Figure supplement 1. VEGFR3 and DAPI staining of a longitudinal section different portions of the aorta. Scale bar: 50 μm.
DOI: 10.7554/eLife.04645.015
Baeyens et al. eLife 2015;4:e04645. DOI: 10.7554/eLife.04645 13 of 16
Research article Cell biology | Human biology and medicine
Author contributions
NB, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or
revising the article; SN, Acquisition of data, Analysis and interpretation of data; BGC, Helped with
experimental design, Analysis and interpretation of data; TDR, KVD, COM, Development of
analytical tools; JH, Acquisition of data, Contributed unpublished essential data or reagents; HML,
Design of the flow chamber; AE, J-LT, Provided critical ideas about the use of the VEGFR3
endothelial inducible KO mice, Contributed unpublished essential data or reagents; JDH, Provided
the original idea, Contributed unpublished essential data or reagents; MAS, Provided the original
idea, Conception and design, Analysis and interpretation of data, Drafting or revising the article
Ethics
Animal experimentation: All animal experiments were performed in accordance with the
recommendations in the Guide for the Care and Use of Laboratory Animals of the National
Institutes of Health and approved by the Institutional Care and Use Committee of Yale University
(protocol #11406).
References
Aranguren XL, Agirre X, Beerens M, Coppiello G, Uriz M, Vandersmissen I, Benkheil M, Panadero J, Aguado N,
Pascual-Montano A, Segura V, Pro´sper F, Luttun A. 2013. Unraveling a novel transcription factor code
determining the human arterial-specific endothelial cell signature. Blood 122:3982–3992. doi: 10.1182/blood-
2013-02-483255.
Baeyens N, Mulligan-Kehoe MJ, Corti F, Simon DD, Ross TD, Rhodes JM, Wang TZ, Mejean CO, Simons M,
Humphrey J, Schwartz MA. 2014. Syndecan 4 is required for endothelial alignment in flow and atheroprotective
signaling. Proceedings of the National Academy of Sciences of USA 111:17308–17313. doi: 10.1073/pnas.
1413725111.
Berk BC. 2008. Atheroprotective signaling mechanisms activated by steady laminar flow in endothelial cells.
Circulation 117:1082–1089. doi: 10.1161/CIRCULATIONAHA.107.720730.
Boito S, Struijk PC, Ursem NT, Stijnen T, Wladimiroff JW. 2002. Umbilical venous volume flow in the normally
developing and growth-restricted human fetus. Ultrasound in Obstetrics & Gynecology 19:344–349.
doi: 10.1046/j.1469-0705.2002.00671.x.
Bond M, Fabunmi RP, Baker AH, Newby AC. 1998. Synergistic upregulation of metalloproteinase-9 by growth
factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Letters
435:29–34. doi: 10.1016/S0014-5793(98)01034-5.
Bussmann J, Schulte-Merker S. 2011. Rapid BAC selection for tol2-mediated transgenesis in zebrafish.
Development 138:4327–4332. doi: 10.1242/dev.068080.
Bussmann J, Wolfe SA, Siekmann AF. 2011. Arterial-venous network formation during brain vascularization involves
hemodynamic regulation of chemokine signaling. Development 138:1717–1726. doi: 10.1242/dev.059881.
Calvo CF, Fontaine RH, Soueid J, Tammela T, Makinen T, Alfaro-Cervello C, Bonnaud F, Miguez A, Benhaim L, Xu
Y, Barallobre MJ, Moutkine I, Lyytikka¨ J, Tatlisumak T, Pytowski B, Zalc B, Richardson W, Kessaris N, Garcia-
Verdugo JM, Alitalo K, Eichmann A, Thomas JL. 2011. Vascular endothelial growth factor receptor 3 directly
regulates murine neurogenesis. Genes & Development 25:831–844. doi: 10.1101/gad.615311.
Cannon WB. 1929. Organization for physiological homeostasis. Physiological Reviews 9:399–431.
Cardamone L, Humphrey JD. 2012. Arterial growth and remodelling is driven by hemodynamics. Modeling of
physiological flows. Springer. p. 187–203.
Castier Y, Ramkhelawon B, Riou S, Tedgui A, Lehoux S. 2009. Role of NF-kappaB in flow-induced vascular
remodeling. Antioxidants & Redox Signaling 11:1641–1649. doi: 10.1089/ars.2008.2393.
Christensen RD, Baer VL, Gerday E, Sheffield MJ, Richards DS, Shepherd JG, Snow GL, Bennett ST, Frank EL,
Oh W. 2014. Whole-blood viscosity in the neonate: effects of gestational age, hematocrit, mean corpuscular
volume and umbilical cord milking. Journal of Perinatology 34:16–21. doi: 10.1038/jp.2013.112.
Coon BG, Baeyens N, et al. 2015. Intra-membrane binding of VE-cadherin to VEGFR2 and VEGFR3 assembles the
endothelial mechanosensory complex. Journal of Cell Biology. In press.
Corti P, Young S, Chen CY, Patrick MJ, Rochon ER, Pekkan K, Roman BL. 2011. Interaction between alk1 and blood
flow in the development of arteriovenous malformations. Development 138:1573–1582. doi: 10.1242/dev.060467.
Covassin LD, Villefranc JA, Kacergis MC, Weinstein BM, Lawson ND. 2006. Distinct genetic interactions between
multiple Vegf receptors are required for development of different blood vessel types in zebrafish. Proceedings of
the National Academy of Sciences of USA 103:6554–6559. doi: 10.1073/pnas.0506886103.
Dixon JB, Greiner ST, Gashev AA, Cote GL, Moore JE, Zawieja DC. 2006. Lymph flow, shear stress,
and lymphocyte velocity in rat mesenteric prenodal lymphatics. Microcirculation 13:597–610. doi: 10.1080/
10739680600893909.
Dolan JM, Meng H, Singh S, Paluch R, Kolega J. 2011. High fluid shear stress and spatial shear stress gradients
affect endothelial proliferation, survival, and alignment. Annals of Biomedical Engineering 39:1620–1631.
doi: 10.1007/s10439-011-0267-8.
Baeyens et al. eLife 2015;4:e04645. DOI: 10.7554/eLife.04645 14 of 16
Research article Cell biology | Human biology and medicine
Dolan JM, Sim FJ, Meng H, Kolega J. 2012. Endothelial cells express a unique transcriptional profile under very
high wall shear stress known to induce expansive arterial remodeling. American Journal of Physiology Cell
physiology 302:C1109–C1118. doi: 10.1152/ajpcell.00369.2011.
Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K, Breitman M, Alitalo K. 1998.
Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282:946–949. doi: 10.1126/
science.282.5390.946.
Dupuis-Girod S, Bailly S, Plauchu H. 2010. Hereditary hemorrhagic telangiectasia: from molecular biology to
patient care. Journal of Thrombosis and Haemostasis 8:1447–1456. doi: 10.1111/j.1538-7836.2010.03860.x.
Godin D, Ivan E, Johnson C, Magid R, Galis ZS. 2000. Remodeling of carotid artery is associated with increased
expression of matrix metalloproteinases in mouse blood flow cessation model. Circulation 102:2861–2866.
doi: 10.1161/01.CIR.102.23.2861.
Gu W, Bra¨nnstro¨m T, Jiang W, Bergh A, Wester P. 2001. Vascular endothelial growth factor-A and -C protein up-
regulation and early angiogenesis in a rat photothrombotic ring stroke model with spontaneous reperfusion. Acta
Neuropathologica 102:216–226.
Haiko P, Makinen T, Keskitalo S, Taipale J, Karkkainen MJ, Baldwin ME, Stacker SA, Achen MG, Alitalo K. 2008.
Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3
deletion in mouse embryos. Molecular and Cellular Biology 28:4843–4850. doi: 10.1128/MCB.02214-07.
Heil M, Schaper W. 2004. Influence of mechanical, cellular, and molecular factors on collateral artery growth
(arteriogenesis). Circulation Research 95:449–458. doi: 10.1161/01.RES.0000141145.78900.44.
Herwig MC, Mu¨ller KM, Mu¨ller AM. 2008. Endothelial VE-cadherin expression in human lungs. Pathology, Research
and Practice 204:725–730. doi: 10.1016/j.prp.2008.04.014.
Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, Breitman M, Alitalo K. 1995.
Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during
development. Proceedings of the National Academy of Sciences of USA 92:3566–3570. doi: 10.1073/pnas.92.8.
3566.
Kamiya A, Bukhari R, Togawa T. 1984. Adaptive regulation of wall shear stress optimizing vascular tree function.
Bulletin of Mathematical Biology 46:127–137. doi: 10.1007/BF02463726.
Kamiya A, Togawa T. 1980. Adaptive regulation of wall shear stress to flow change in the canine carotid artery. The
American Journal of Physiology 239:H14–H21.
Kiserud T, Rasmussen S. 1998. How repeat measurements affect the mean diameter of the umbilical vein and the
ductus venosus. Ultrasound in Obstetrics & Gynecology 11:419–425. doi: 10.1046/j.1469-0705.1998.11060419.x.
Kohler TR, Kirkman TR, Kraiss LW, Zierler BK, Clowes AW. 1991. Increased blood flow inhibits neointimal
hyperplasia in endothelialized vascular grafts. Circulation Research 69:1557–1565. doi: 10.1161/01.RES.69.6.1557.
Ku¨chler AM, Gjini E, Peterson-Maduro J, Cancilla B, Wolburg H, Schulte-Merker S. 2006. Development of the zebrafish
lymphatic system requires VEGFC signaling. Current Biology 16:1244–1248. doi: 10.1016/j.cub.2006.05.026.
Kwon HB, Fukuhara S, Asakawa K, Ando K, Kashiwada T, Kawakami K, Hibi M, Kwon YG, Kim KW, Alitalo K,
Mochizuki N. 2013. The parallel growth of motoneuron axons with the dorsal aorta depends on Vegfc/Vegfr3
signaling in zebrafish. Development 140:4081–4090. doi: 10.1242/dev.091702.
Langheinrich U, Vacun G, Wagner T. 2003. Zebrafish embryos express an orthologue of HERG and are sensitive
toward a range of QT-prolonging drugs inducing severe arrhythmia. Toxicology and Applied Pharmacology 193:
370–382. doi: 10.1016/j.taap.2003.07.012.
Langille BL. 1996. Arterial remodeling: relation to hemodynamics. Canadian Journal of Physiology and
Pharmacology 74:834–841. doi: 10.1139/y96-082.
Langille BL, Bendeck MP, Keeley FW. 1989. Adaptations of carotid arteries of young and mature rabbits to
reduced carotid blood flow. The American Journal of Physiology 256:H931–H939.
Langille BL, O’Donnell F. 1986. Reductions in arterial diameter produced by chronic decreases in blood flow are
endothelium-dependent. Science 231:405–407. doi: 10.1126/science.3941904.
Levesque MJ, Nerem RM. 1985. The elongation and orientation of cultured endothelial cells in response to shear
stress. Journal of Biomechanical Engineering 107:341–347. doi: 10.1115/1.3138567.
Lipowsky HH, Usami S, Chien S. 1980. In vivo measurements of ‘apparent viscosity’ and microvessel hematocrit in
the mesentery of the cat. Microvascular Research 19:297–319. doi: 10.1016/0026-2862(80)90050-3.
Magid R, Murphy TJ, Galis ZS. 2003. Expression of matrix metalloproteinase-9 in endothelial cells is differentially
regulated by shear stress. Role of c-Myc. The Journal of Biological Chemistry 278:32994–32999. doi: 10.1074/jbc.
M304799200.
Mohan S, Mohan N, Sprague EA. 1997. Differential activation of NF-kappa B in human aortic endothelial cells
conditioned to specific flow environments. The American Journal of Physiology 273:C572–C578.
Nicoli S, Knyphausen CP, Zhu LJ, Lakshmanan A, Lawson ND. 2012. miR-221 is required for endothelial tip cell
behaviors during vascular development. Developmental Cell 22:418–429. doi: 10.1016/j.devcel.2012.01.008.
Padilla J, Simmons GH, Bender SB, Arce-Esquivel AA, Whyte JJ, Laughlin MH. 2011. Vascular effects of
exercise: endothelial adaptations beyond active muscle beds. Physiology 26:132–145. doi: 10.1152/
physiol.00052.2010.
Pitulescu ME, Schmidt I, Benedito R, Adams RH. 2010. Inducible gene targeting in the neonatal vasculature and
analysis of retinal angiogenesis in mice. Nature Protocols 5:1518–1534. doi: 10.1038/nprot.2010.113.
Pusztaszeri MP, Seelentag W, Bosman FT. 2006. Immunohistochemical expression of endothelial markers CD31,
CD34, von Willebrand factor, and Fli-1 in normal human tissues. The Journal of Histochemistry and Cytochemistry
54:385–395. doi: 10.1369/jhc.4A6514.2005.
Rodbard S. 1975. Vascular caliber. Cardiology 60:4–49. doi: 10.1159/000169701.
Baeyens et al. eLife 2015;4:e04645. DOI: 10.7554/eLife.04645 15 of 16
Research article Cell biology | Human biology and medicine
Saito T, Hasegawa Y, Ishigaki Y, Yamada T, Gao J, Imai J, Uno K, Kaneko K, Ogihara T, Shimosawa T, Asano T,
Fujita T, Oka Y, Katagiri H. 2013. Importance of endothelial NF-kappaB signalling in vascular remodelling and
aortic aneurysm formation. Cardiovascular Research 97:106–114. doi: 10.1093/cvr/cvs298.
Schaper W. 2009. Collateral circulation: past and present. Basic Research in Cardiology 104:5–21. doi: 10.1007/
s00395-008-0760-x.
Silvestre JS, Mallat Z, Tedgui A, Le´vy BI. 2008. Post-ischaemic neovascularization and inflammation. Cardiovascular
Research 78:242–249. doi: 10.1093/cvr/cvn027.
Silvestre JS, Smadja DM, Le´vy BI. 2013. Postischemic revascularization: from cellular and molecular mechanisms to
clinical applications. Physiological Reviews 93:1743–1802. doi: 10.1152/physrev.00006.2013.
Sun HW, Li CJ, Chen HQ, Lin HL, Lv HX, Zhang Y, Zhang M. 2007. Involvement of integrins, MAPK, and NF-kappaB
in regulation of the shear stress-induced MMP-9 expression in endothelial cells. Biochemical and Biophysical
Research Communications 353:152–158. doi: 10.1016/j.bbrc.2006.12.002.
Suo J, Ferrara DE, Sorescu D, Guldberg RE, Taylor WR, Giddens DP. 2007. Hemodynamic shear stresses in
mouse aortas: implications for atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 27:346–351.
doi: 10.1161/01.ATV.0000253492.45717.46.
Sweet DT, Chen Z, Givens CS, Owens AP III, Rojas M, Tzima E. 2013. Endothelial Shc regulates arteriogenesis
through dual control of arterial specification and inflammation via the notch and nuclear factor-kappa-light-chain-
enhancer of activated B-cell pathways. Circulation Research 113:32–39. doi: 10.1161/CIRCRESAHA.113.301407.
Tammela T, Zarkada G, Wallgard E, Murtoma¨ki A, Suchting S, Wirzenius M, Waltari M, Hellstro¨m M, Schomber T,
Peltonen R, Freitas C, Duarte A, Isoniemi H, Laakkonen P, Christofori G, Yla¨-Herttuala S, Shibuya M, Pytowski B,
Eichmann A, Betsholtz C, Alitalo K. 2008. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular
network formation. Nature 454:656–660. doi: 10.1038/nature07083.
Thoma R. 1893. Untersuchungen u¨ber die Histogenese und Histomechanik des Gefa¨ßsystems. Stuttgart: Enke
Verlag.
Tronc F, Wassef M, Esposito B, Henrion D, Glagov S, Tedgui A. 1996. Role of NO in flow-induced remodeling
of the rabbit common carotid artery. Arteriosclerosis, Thrombosis, and Vascular Biology 16:1256–1262.
doi: 10.1161/01.ATV.16.10.1256.
Tuttle JL, Nachreiner RD, Bhuller AS, Condict KW, Connors BA, Herring BP, Dalsing MC, Unthank JL. 2001. Shear
level influences resistance artery remodeling: wall dimensions, cell density, and eNOS expression. American
Journal of Physiology Heart and Circulatory Physiology 281:H1380–H1389.
Tzima E, Irani-Tehrani M, Kiosses WB, Dejana E, Schultz DA, Engelhardt B, Cao G, DeLisser H, Schwartz MA. 2005.
A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 437:
426–431. doi: 10.1038/nature03952.
Usami S, Chen HH, Zhao Y, Chien S, Skalak R. 1993. Design and construction of a linear shear stress flow chamber.
Annals of Biomedical Engineering 21:77–83. doi: 10.1007/BF02368167.
Viggers RF, Wechezak AR, Sauvage LR. 1986. An apparatus to study the response of cultured endothelium to
shear stress. Journal of Biomechanical Engineering 108:332–337. doi: 10.1115/1.3138624.
Villefranc JA, Nicoli S, Bentley K, Jeltsch M, Zarkada G, Moore JC, Gerhardt H, Alitalo K, Lawson ND. 2013. A
truncation allele in vascular endothelial growth factor c reveals distinct modes of signaling during lymphatic and
vascular development. Development 140:1497–1506. doi: 10.1242/dev.084152.
Walshe TE, Saint-Geniez M, Maharaj AS, Sekiyama E, Maldonado AE, D’Amore PA. 2009. TGF-beta is required for
vascular barrier function, endothelial survival and homeostasis of the adult microvasculature. PLOS ONE 4:e5149.
doi: 10.1371/journal.pone.0005149.
Wang C, Lu H, Schwartz MA. 2012. A novel in vitro flow system for changing flow direction on endothelial cells.
Journal of Biomechanics 45:1212–1218. doi: 10.1016/j.jbiomech.2012.01.045.
Wang Y, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek ML, Sakakibara A, Adams S, Davy A, Deutsch U, Lu¨thi
U, Barberis A, Benjamin LE, Ma¨kinen T, Nobes CD, Adams RH. 2010. Ephrin-B2 controls VEGF-induced
angiogenesis and lymphangiogenesis. Nature 465:483–486. doi: 10.1038/nature09002.
Ward MR, Pasterkamp G, Yeung AC, Borst C. 2000. Arterial remodeling. Mechanisms and clinical implications.
Circulation 102:1186–1191. doi: 10.1161/01.CIR.102.10.1186.
Witmer AN, Dai J, Weich HA, Vrensen GF, Schlingemann RO. 2002. Expression of vascular endothelial growth
factor receptors 1, 2, and 3 in quiescent endothelia. The Journal of Histochemistry and Cytochemistry 50:
767–777. doi: 10.1177/002215540205000603.
Yaniv K, Isogai S, Castranova D, Dye L, Hitomi J, Weinstein BM. 2006. Live imaging of lymphatic development in
the zebrafish. Nature Medicine 12:711–716. doi: 10.1038/nm1427.
Baeyens et al. eLife 2015;4:e04645. DOI: 10.7554/eLife.04645 16 of 16
Research article Cell biology | Human biology and medicine
